Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic eltrombopag olamine 25 mg vs Revolade in healthy Thai volunteers (fasting, single-dose, crossover)
TCTR20250910007Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of eltrombopag (2 arms), sponsored by International Bio Service. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
eltrombopag
Beyond the preview
Go deeper on TCTR20250910007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250910007.